Other

Human Genome agrees to GlaxoSmithKline takeover (Update)

(AP) — U.K. drug maker GlaxoSmithKline has secured its takeover of longtime partner Human Genome Sciences after agreeing to pay more, a move to expand GSK's drug portfolio in crucial areas: biologic drugs and treatments ...

page 3 from 3